Khrom Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Acadia Healthcare
ACHC
|
+$56.4M |
| 2 |
United Airlines
UAL
|
+$45M |
| 3 |
HCA Healthcare
HCA
|
+$29.1M |
| 4 |
MAGN
Magnera Corp
MAGN
|
+$26.8M |
| 5 |
INGM
Ingram Micro Holding
INGM
|
+$21.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Live Nation Entertainment
LYV
|
+$51.8M |
| 2 |
Chemours
CC
|
+$22.6M |
| 3 |
Asbury Automotive
ABG
|
+$15.3M |
| 4 |
Synchrony
SYF
|
+$8.97M |
| 5 |
TD Synnex
SNX
|
+$6.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 23.43% |
| 2 | Financials | 20.67% |
| 3 | Technology | 17.07% |
| 4 | Materials | 16.11% |
| 5 | Healthcare | 12.88% |
Similar funds
Khrom Capital Management's Q4 2024 Portfolio in Review
As of Q4 2024, Khrom Capital Management held 23 positions worth $883M, up 12% from $787M the previous quarter. Its ten largest holdings account for 81% of the portfolio.
Khrom Capital Management deployed $163M of net new capital in Q4 2024, opening 7 new positions and adding to 6 existing holdings. Its largest new stake was Acadia Healthcare: 1,251,002 shares worth $49.6M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 23% of assets, down from 28% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Chemours, an estimated $22.6M trimmed.
- Khrom Capital Management's largest Q4 2024 buy was Acadia Healthcare: 1,251,002 shares worth $49.6M.
- Khrom Capital Management added most to Signet Jewelers in Q4 2024, an estimated $20.9M increase.
- Khrom Capital Management's biggest Q4 2024 reduction was Chemours, cutting an estimated $22.6M.
- Khrom Capital Management fully exited Live Nation Entertainment in Q4 2024, selling an estimated $51.8M.
- Khrom Capital Management's ten largest holdings make up 81% of its $883M portfolio in Q4 2024.
- Khrom Capital Management opened 7 new positions and closed 5 in Q4 2024.
- Khrom Capital Management's portfolio value rose 12% quarter-over-quarter to $883M.
Based on Khrom Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.